Mutant KRAS-targeted Long Peptide Vaccine

· Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Mutant KRAS-targeted Long Peptide Vaccine, covering 2025-12-03 to 2025-12-03. Get the full timeline:

Most recent: Clinical Trial Update: Mutant KRAS -Targeted Long Peptide Vaccine for Patients at High Risk of Developing Pancreatic Cancer [Phase 1]